REPORT - State of China Life Sciences: 2019

With new investment records set across the board, it is the golden era of healthcare in China due to robust government support, sweeping regulatory changes, a strong talent base and more. Review the report compiled by ChinaBio® Group that uncovers the activity in 2018. Read the latest analysis of life science investment activity to get ahead for ChinaBio® Partnering Forum in Shanghai, May 8-9!

Topics Include:

• VC Funds Raised
• VC Investment
• M&A Activity
• IPOs
• Partnering Activity

Get a sneak peek at the 2018 investment activity in China from the report. New records were set across the board!

_{Source: ChinaBio^® Consulting}